InsidersTradesSigma
Explore the full management transaction log of HLB생명과학, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, HLB생명과학 has published 9 public disclosures. Market capitalisation: €543.1bn. The latest transaction was filed on 7 October 2022 (Mixed). Among the most active insiders: HLB. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
9 of 9 declarations